Peripheral Nerve Block vs Spinal Anesthesia in Hip Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
Anesthesia plays an important role in the patient's outcome: each anesthesiological technique has a different cardiovascular impact, because they act differently on the autonomic nervous system, which in turn regulates heart rate, myocardial contractility and vascular tone. Subarachnoid anesthesia can result in a reduction in cardiac output, hypotension and bradycardia due to blockage of the nerve fibers of the sympathetic system, while peripheral nerve block is associated with a lower impact on the autonomic nervous system, therefore less influence on hemodynamic changes compared to subarachnoid anesthesia. Hypotension can lead to myocardial ischaemia, especially in patients at high surgical risk. In addition, peripheral nerve block allows for better coverage from postoperative pain compared to subarachnoid anesthesia in patients undergoing hip surgery. This leads to less postoperative stress, with less impact on cardiac and respiratory function. Numerous studies have shown the efficacy and safety of regional anesthesia in hip surgery. This study aims to compare the hemodynamic changes of subarachnoid anesthesia and peripheral nerve block in patients who underwent total and partial hip replacement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 6, 2020
CompletedFirst Posted
Study publicly available on registry
August 10, 2020
CompletedAugust 10, 2020
August 1, 2020
11 months
August 6, 2020
August 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change of the systolic blood pressure
Systolic blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery
During anesthetic and surgery procedures
Change of the diastolic blood pressure
Diastolic blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery
During anesthetic and surgery procedures
Change of the mean blood pressure
Mean blood pressure will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery
During anesthetic and surgery procedures
Change of the heart rate
Heart rate will be evalueted after sedation, at the end of the anesthestic procedure, and then every 2.5 minutes up to the 20th minute. Then at the beginning of the surgery and every 5 minutes until the end of the surgery
During anesthetic and surgery procedures
Secondary Outcomes (15)
Change in the onset time of the nerve block
Up to 20 minutes
Change in the degree of the sensory block
Up to 20 minutes after the end of the anesthetic procedure
Change of the Motor block degree
Up to 20 minutes after the end of the anesthetic procedure
Amount ephedrine administered during the perioperative period
During anesthetic and surgery procedures
Amount atrophine administered during the perioperative period
During anesthetic and surgery procedures
- +10 more secondary outcomes
Study Arms (2)
Peripheral nerve block
ACTIVE COMPARATORThe participant will receive a combination of lumbar plexus block, sciatic nerve block, lateral femoral cutaneous nerve block and lateral branch of iliohypogastric nerve block
Spinal anesthesia
ACTIVE COMPARATORThe participant will receive a combination of spinal anesthesia and lumbar plexus block
Interventions
In this group, four nerve blocks will be associated to ensure adequate anesthesia and analgesia during hip surgery. Lumbar plexus and sciatic nerve blocks will be performed with a needle connected to an electrical nerve stimulation. The needle will be advanced until contraction of the femoral quadriceps muscle and plantar or dorsal flexion of the foot will be detected respectively. For both, a mixture of mepivacaine and levobupivacaine will be injected. Lateral femoral cutaneous nerve block will be performed with the ultrasound technique. After identifying the nerve, a needle will be inserted with an "in plane" approach and will be injected. Lateral branch of iliohypogastric nerve block will be executed with the "De Visme approach". Along the iliac crest (range between 7 and 11 cm from the anterior superior iliac spine) a needle will be inserted until bone contact is found. Then a mixture of mepivacaine and levobupivacaine will be injected.
In this group, spinal anesthesia will be performed to ensure anesthesia during surgery, while lumbar plexus block will be performed to ensure postoperative analgesia Spinal anesthesia will be performed with a 25 G needle and 12 mg 0.5% levobupivacaine will be injected. Lumbar plexus block will be performed with a needle connected to an electrical nerve stimulation. The needle will be advanced until contraction of the femoral quadriceps muscle will be detected. 20 ml 0.5% levobupivacaine will be injected.
Eligibility Criteria
You may qualify if:
- Subject has signed and dated an Informed Consent Form
- Subject is classified as a ASA (American Society of Anesthesiologists) status I-IV
- Subject is age 18- 99 years old
- Patients undergoing total hip arthroplasty
You may not qualify if:
- Subject inability to provide adequate informed consent
- Study refusal
- Age younger than 18 years
- Contraindication to regional anesthesia
- Allergy to local anesthetics
- Neurological disease of the lower limbs
- Moderate or severe dementia disease
- Psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedali Riuniti di Ancona - Università politecnica delle marche
Ancona, 60126, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego Tavoletti, MD
Ospedali riuniti di Ancona-Università politecnica delle Marche
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 6, 2020
First Posted
August 10, 2020
Study Start
January 1, 2019
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
August 10, 2020
Record last verified: 2020-08